Jefferies analyst Corey Tarlowe maintained a Buy rating on Target (TGT – Research Report) today and set a price target of $195.00. The ...
Shares of major U.S. drugmakers fell on Friday after President-elect Donald Trump picked anti-vaccine activist Robert F.